The low- and high-expressions of CMTM6 in gastric cancer tissues were 46.7% (57/122) and 53.3% (65/122), respectively, and the negative and positive expressions of PD-L1 were 35 (28.7%) and 87 (71.3%), respectively (Table 1). The gene discussed is CMTM6; the disease is gastric cancer.